IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Qiming U.S. Ventures Management, LLC

Q4 2024 Holdings

Filed 2025-01-28 | 6 holdings | $51.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Jasper Therapeutics Inc(JSPR)COM NEW471871202$19.9M928,96438.8%
Tourmaline BIO Inc(TRML)COM89157D105$15.0M741,69129.4%
Korro BIO Inc(KRRO)COM500946108$14.0M368,08527.4%
Ventyx Biosciences Inc(VTYX)COM92332V107$902.8K412,2251.8%
Hillevax IncCOM43157M102$771.3K372,6151.5%
Kezar Life Sciences Inc(KZR)COM NEW49372L209$556.9K82,8711.1%